Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar;44(1):13-8.
doi: 10.2478/v10019-010-0007-y. Epub 2010 Mar 18.

Genetic markers in oligodendroglial tumours

Affiliations

Genetic markers in oligodendroglial tumours

Tomaz Velnar et al. Radiol Oncol. 2010 Mar.

Abstract

Background: Oliogodendrogliomas are brain tumours composed of the cells resembling oligodendrocytes. They represent the third most common glial tumour, comprising 2.5% of all primary brain tumours and 5-20% of all gliomas.

Conclusions: Oligodendroglial tumours with 1p and 19q loss demonstrate a better overall prognosis due to more indolent clinical behaviour and higher sensitivity to treatment. Additionally, 1p and 19q loss is a marker of clinical utility, helping to assess tumour sensitivity to chemotherapy and harbouring the potential for improving the diagnosis and survival of oligodendroglioma patients as well as future clinical practice.

Keywords: chemotherapy; genetic markers; oligodendroglioma; prognosis.

PubMed Disclaimer

References

    1. Gilbert MR, Lang FF. Management of patients with low-grade gliomas. Neurol Clin. 2007;25:1073–88. - PubMed
    1. Strojnik T, Gornik-Kramberger K. [Stereotactic biopsy of brain tumours – Maribor experience with MHT stereotaxy system]. [Slovenian] Zdrav Vestn. 2008;77:601–8.
    1. Asthagiri AR, Pouratian N, Sherman J, Ahmed G, Shaffrey ME. Advances in brain tumor surgery. Neurol Clin. 2007;25:975–1003. - PubMed
    1. Engelhard HH, Stelea A, Mundt A. Oligodendroglioma and anaplastic oligodendroglioma: clinical features, treatment and prognosis. Surg Neurol. 2003;60:443–56. - PubMed
    1. Strojnik A. Search of the shortest regimen: fractionation of a fully isoeffective combination of hyperfractionated and hypofractionated treatment. Radiol Oncol. 2008;42:170–2.

LinkOut - more resources